Biologics Research Review, Issue 22 - Dermatology focus

In this issue:

Retention/regain of response with secukinumab in psoriasis
Immunogenicity and pharmacokinetics, efficacy and safety of tildrakizumab
Long-term efficacy and safety of brodalumab for psoriasis
Long-term efficacy and safety of dupilumab for atopic dermatitis
Dupilumab in adolescents with moderate-to-severe atopic dermatitis
Dupilumab in paediatric patients with moderate-to-severe atopic dermatitis
Comorbid allergic contact dermatitis in patients receiving dupilumab
Nivolumab immune-related adverse events and melanoma survival
Brentuximab vedotin for CD30+ mycosis fungoides
Body weight gain with some biologics in psoriasis
Suicidal behaviour and TNF-α antagonists for HS

Please login below to download this issue (PDF)

Subscribe